California start-up Bionaut Labs will conduct its first clinical trials on sending miniature robots deep inside the human skull to treat brain disorders
The tiny injectable robots can be guided through the brain using magnets.
Micro-robot technology "that used to be science fantasy in the 1950s and 1960s" is now "scientific fact," according to Michael Shpigelmacher, Bionaut Labs' founder and CEO.
Working with Germany's famed Max Planck research institutes, Bionaut Labs chose magnetic energy over optical or ultrasonic means to propel the robots because it is non-harmful to the human body.
Magnetic coils implanted outside the patient's skull are connected to a computer that can remotely and delicately navigate the micro-robot into the damaged area of the brain before withdrawing it the same way.
Unlike an MRI, the entire system is portable and utilizes 10 to 100 times less electricity.
The robot, which is a metal cylinder just a few millimeters long and shaped like a small bullet, follows a pre-programmed trajectory through a gel-filled container that mimics the density of the human brain in a simulation observed by AFP.
When the robot gets close enough to a pouch filled with blue liquid, it accelerates like a rocket and pierces the sack with its pointed end, allowing liquid to gush out.
When clinical trials begin in two years, the inventors want to use the robot to penetrate fluid-filled cysts in the brain.
The method could be used to cure Dandy-Walker Syndrome, a rare brain abnormality that affects youngsters if it is successful.
Cysts the size of a golf ball can form in congenital illness sufferers, swelling and increased pressure on the brain, initiating a slew of serious neurological problems.
Bionaut Labs has already tested its robots on large animals like lambs and pigs, and according to Shpigelmacher, "the evidence suggests that the technology is safe for us."
If approved, the robots could provide significant benefits over currently available therapies for brain illnesses.
Last year, the US Food and Drug Administration (FDA) awarded Bionaut Labs clearance to begin clinical studies for Dandy-Walker Syndrome and malignant gliomas, which are cancerous brain tumors that are frequently considered inoperable.
The micro-robots will be used to inject anti-cancer medications directly into brain tumors in a "surgical strike" in cancerous brain tumors.


NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Dow Hits Record High as Healthcare and Consumer Stocks Lead Wall Street Rally
SoftBank to Invest €75 Billion in France AI Data Center Expansion by 2031
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
NIO CEO Says China’s Auto Industry Has Passed Its Golden Era Amid Weak Car Sales
Neuralink Expands Brain Implant Trials with 12 Global Patients
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
New World Screwworm Found Near U.S. Border Raises Threat to Cattle Industry and Beef Prices
Nvidia and Microsoft to Launch AI-Powered Windows PCs at Computex 2026
European EV Sales Surge in April 2026 as Tesla and Chinese Automakers Gain Ground
Rising Airfares May Challenge Cruise Industry Growth Ahead of 2027 Booking Season
US Quantum Stocks Surge After $2 Billion Government Investment
DOJ Investigates Group Linked to Reid Hoffman Over E. Jean Carroll Lawsuit Funding
South Korea Central Bank Holds Interest Rates Steady Amid Inflation Concerns
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Oil Prices Fall as Markets Await U.S.-Iran Peace Deal Decision 



